What is a liver hemangioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Liver Hemangioma: Definition and Management

A liver hemangioma is the most common benign liver tumor consisting of clusters of blood-filled cavities lined by endothelial cells and fed by the hepatic artery. 1, 2 These vascular malformations are typically asymptomatic and discovered incidentally during imaging studies performed for unrelated reasons.

Epidemiology and Characteristics

  • Prevalence: 0.4% to 8% of the general population 1
  • Female predominance: Female to male ratio of up to 5:1 1
  • Classification by size:
    • Small: Few mm to 3 cm
    • Medium: 3-10 cm
    • Giant: >10 cm 2, 3

Pathophysiology

Liver hemangiomas are developmental vascular malformations rather than true neoplasms. They consist of:

  • Blood-filled cavities lined by endothelial cells
  • Blood supply from the hepatic artery
  • Lack of portal venous supply 4

Clinical Presentation

  • Asymptomatic: Most hemangiomas (>50%) are found incidentally 2, 5
  • Symptomatic: When symptoms occur, they typically include:
    • Right upper quadrant abdominal pain (most common symptom, especially in lesions >5 cm)
    • Feeling of fullness or early satiety
    • Nausea or vomiting (with larger lesions)

Imaging Characteristics

Ultrasound

  • Small lesions (<2 cm): Uniformly echogenic
  • Medium lesions (2-5 cm): Predominantly echogenic
  • Large lesions (>5 cm): Mixed echogenicity 4

Contrast-Enhanced Ultrasound (CEUS)

  • Peripheral nodular enhancement (74%) in arterial phase
  • Complete (78%) or incomplete (22%) centripetal filling in portal venous and late phases
  • Diagnostic accuracy: 80-90% 4, 1

MRI

  • High signal intensity on T2-weighted images
  • Peripheral nodular enhancement with progressive centripetal filling on dynamic contrast sequences
  • Accuracy: 95-99% for hemangioma diagnosis 1
  • Superior for lesion characterization in uncertain cases 4

Management Approach

Asymptomatic Hemangiomas

  • Small to medium (<5 cm): No specific treatment or routine follow-up required 1
  • Medium to large (5-10 cm): Annual ultrasound monitoring 1
  • Giant (>10 cm): Ultrasound monitoring every 6 months 1

Symptomatic Hemangiomas

Intervention should be considered for:

  • Progressive abdominal pain (most common indication)
  • Rapid growth
  • High-risk features (peripheral location, exophytic growth)
  • Size >10 cm with symptoms 1, 3

Treatment Options

  1. Surgical resection: Preferred for symptomatic lesions >5 cm 3, 6

    • Enucleation is the preferred surgical technique with fewer complications than formal hepatectomy 5, 6
  2. Non-surgical options:

    • Transarterial embolization
    • Radiofrequency ablation (limited role for smaller symptomatic lesions) 1

Special Considerations

Pregnancy

  • Pregnancy is not contraindicated with liver hemangiomas
  • For hemangiomas >5 cm: Ultrasound monitoring each trimester
  • For hemangiomas >10 cm: More vigilant monitoring due to 5% rupture risk 1

Complications

  • Rupture risk: <1% for small lesions, 3.2% for giant hemangiomas (5-10 cm), 5% for lesions >10 cm 1
  • Kasabach-Merritt syndrome (disseminated intravascular coagulation): Rare but requires intervention 6

Follow-up

  • Post-surgical: Imaging at 3 months to confirm complete resection
  • No long-term follow-up needed after complete resection 1

Important Caveats

  • Liver biopsy should be avoided if imaging strongly suggests hemangioma due to bleeding risk 1
  • Atypical hemangiomas can mimic malignant lesions such as hepatocellular carcinoma or cholangiocarcinoma, requiring careful radiological assessment 7
  • Always rule out other causes of abdominal symptoms before attributing them to hemangioma 5

Liver hemangiomas generally follow a benign course, with less than 40% showing progression over time 5. The management approach should be guided by the presence of symptoms, size of the lesion, and associated risk factors.

References

Guideline

Liver Hemangioma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatic hemangioma -review-.

Journal of medicine and life, 2015

Research

Management of liver hemangiomas according to size and symptoms.

Journal of gastroenterology and hepatology, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatic hemangioma: What internists need to know.

World journal of gastroenterology, 2020

Research

Management of giant liver hemangiomas: an update.

Expert review of gastroenterology & hepatology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.